ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Harbor Multi asset Explorer ETF

Harbor Multi asset Explorer ETF (MAPP)

23.405
0.0525
( 0.22% )
Updated: 12:17:00

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
23.405
Bid
-
Ask
-
Volume
794
23.405 Day's Range 23.45
20.4742 52 Week Range 24.19
Previous Close
23.3525
Open
23.45
Last Trade
7
@
23.405
Last Trade Time
10:36:00
Average Volume (3m)
144
Financial Volume
$ 18,619
VWAP
23.45

MAPP Latest News

MAP Pharmaceuticals Announces Initiation of LEVADEX(TM) Pharmacokinetics Trial

--Trial to be used in support of NDA submission-- MOUNTAIN VIEW, Calif., Feb. 16 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the Company initiated a...

MAP Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Jan. 6 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the company will present at the 28th Annual J.P. Morgan Healthcare Conference...

MAP Pharmaceuticals Secures $60 Million Committed Equity Financing Facility

MOUNTAIN VIEW, Calif., Nov. 12 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that it has secured a committed equity financing facility under which it may sell...

MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference

MOUNTAIN VIEW, Calif., Nov. 11 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the company will present at the Lazard Capital Markets 6th Annual Healthcare...

MAP Pharmaceuticals Completes Interim Safety Review of LEVADEX(TM) Open-Label Safety Extension in More Than 400 Patients

MOUNTAIN VIEW, Calif., Oct. 29 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that it has completed a planned interim safety review of the open-label...

MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of

-- Analysis Shows Potential of LEVADEX to Treat a Broad Spectrum of Migraine -- -- Company to Host Webcast on Monday, September 14th at 7:15 a.m. ET -- MOUNTAIN VIEW, Calif., Sept. 10...

MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences

- Investor Webcast to Discuss Phase 3 LEVADEX(TM) Data Presented in Late-Breaking Session at the 14th Congress of the International Headache Society - MOUNTAIN VIEW, Calif., Sept. 2...

AstraZeneca Terminates MAP Pharma Pact, Sees $44 Million charge In 2Q

AstraZeneca PLC (AZN), a major international healthcare business, said Thursday it has terminated the license agreement with MAP Pharmaceuticals Inc (MAPP), regarding Unit Dose Budesonide, or UDB...

MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration

- Company to Suspend Development of UDB - MOUNTAIN VIEW, Calif., July 9 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that it has received a notice of...

MAP Pharmaceuticals Announces Pricing of Its Initial Public Offering

MOUNTAIN VIEW, Calif., Oct. 5 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. announced today that it has priced its initial public offering of 5,000,000 shares of common stock at a price of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.03510.15019319723223.369923.5623.35257823.4194582SP
40.5852.5635407537222.8223.5622.54518322.99914493SP
12-0.048-0.20466464844623.45324.1922.545114423.66463435SP
261.0654.7672336615922.3424.1921.598427122.93389541SP
522.74513.286544046520.6624.1920.474223222.3852189SP
1563.26516.211519364420.1424.1918.901564020.74265551SP
2603.26516.211519364420.1424.1918.901564020.74265551SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SLXNSilexion Therapeutics Corporation
$ 1.14
(96.55%)
181.5M
RNAZTransCode Therapeutics Inc
$ 13.37
(95.75%)
22.27M
YIBOPlanet Image International Ltd
$ 4.81
(56.17%)
50.21M
TRIBTrinity Biotech PLC
$ 1.1001
(44.75%)
101.18M
TOIIWOncology Institute Inc
$ 0.043
(43.33%)
15.66k
LPTXLeap Therapeutics Inc
$ 0.6498
(-71.12%)
8.62M
STSSSharps Technology Inc
$ 0.4278
(-70.70%)
12.68M
SABSSAB Biotherapeutics Inc
$ 2.24
(-48.62%)
959.55k
INKTMiNK Therapeutics Inc
$ 4.5601
(-48.41%)
116.09k
MGOLMGO Global Inc
$ 0.168717
(-40.38%)
16.59M
NVDANVIDIA Corporation
$ 124.785
(5.37%)
292.68M
HEPAHepion Pharmaceuticals Inc
$ 0.2221
(34.61%)
239.97M
SLXNSilexion Therapeutics Corporation
$ 1.14
(96.55%)
181.5M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.4924
(19.49%)
159.43M
TRIBTrinity Biotech PLC
$ 1.1001
(44.75%)
101.18M

Discussion

View Full Feed
 jangofett jangofett 3 minutes ago
Can't wait for whiners to sell their shares and leave! 🐂🤑🤑🤑🤑🤑
ELTP
DrHigh DrHigh 3 minutes ago
yes I believe she grifted from NWBO to build Cognate value which she cashed out on. so why not do it again
NWBO
JoeForkeyBolo JoeForkeyBolo 3 minutes ago
Two Years Into Novavax Reset, CEO Jacobs Hunts for Silver Linings

BioSpace
January 28, 2025

https://www.biospace.com/business/two-years-into-novavax-reset-ceo-jacobs-hunts-for-silver-linings
NVAX
vlispxpert vlispxpert 3 minutes ago
AMPY Price/Earnings (TTM) 3.45, Forward P/E 5.98
AMPY
cashclan cashclan 3 minutes ago
Considering 690 million



From podcast years ago...

Fishing could be brisk for 73 million...

J105's audited out at .01-.02

Might need to do some consoldating and dusting off of that there ENTI warehouse...29.9 billion /3000:
ENTI
RickNagra RickNagra 3 minutes ago
Oh wow.  Calling all whales.
DBMM
againstallodds againstallodds 3 minutes ago
”…actively pursuing…” That confirms he’s got no permits

Here is JarHead while actively pursuing:

https://investorshub.advfn.com/uimage/uploads/2023/5/4/z[fqlFED3D0C0-7457-492E-857C-89F3E0F46BD7.jpeg
NBRI
Zorax Zorax 4 minutes ago
How many in the visual media aren't credited journalists but just talking heads reading what they are ordered to read? Like hedgeth/heghog who never wrote a thing he read or talked about.
Jp_SHMP Jp_SHMP 4 minutes ago
absolutely
I am here to stay
The way they write their pr and all info in china it's like a poeme

Really liking the slow climb here
In my case, it's a good thing thant all the process take so much time,
4M in and thinking about 5M

Best lotto
IGPK
boi568 boi568 4 minutes ago
I tend to agree. You need real certainty to bet it all like that when you could lose it all. We're not in that situation now. We can have a lot more confidence in the drugs, and we have some money to spare.
AVXL
IB_ IB_ 4 minutes ago
"_🤣_55. Vegas BABY !!!!!"

Been hearing that non-sense for 14 years now,

IB_🤴












'
ELTP
Carjockey2 Carjockey2 4 minutes ago
I rarely have time to sit and watch L2 all day long but seeing as somebody told me they were buying that lot off the ask and it went through at .00075 I'll call it games happy they got the discount though. LOL

Yes it's most definitely being held in this range for a reason
HMBL
tw0122 tw0122 4 minutes ago
$15.40 + 110% Still have some $2.70s bought on the ultimate dip a few weeks ago ...
 some asked why kept Nobel Prize low float amongst some. Ask Martin L King and some others who have hung in there good traders here
RNAZ
StayHumble StayHumble 5 minutes ago
w0w💹MAJOR UPDATE✅$83 Possible PerSEC regulations💹huzzah! https://ih.advfn.com/stock-market/USOTC/ubiquitech-software-pk-UBQU/historical


https://x.com/CorporateUbqu/status/1767983893544566905?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1767983893
UBQU
 stock king 1 stock king 1 5 minutes ago
They put him in prison for fraud if that’s what happened I would be happy . They need to take all his assets to pay the people he took from off lies …. JK buy a chemical mask because both of your company stink like poop.. strong smell of fraud imho
VXIT
vlispxpert vlispxpert 5 minutes ago
CGC churn baby churn ;)
HGilS HGilS 5 minutes ago
News blackout News from a few days ago.

Thanks Sharkey

https://apnews.com/article/trump-health-communications-cdc-hhs-fda-1eeca64c1ccc324b31b779a86d3999a4
ELTP
georgie18 georgie18 5 minutes ago
CDIO...49s starting up again...🥳

georgie18

Member Level
Re: georgie18 post# 388892

Monday, January 27, 2025 11:02:15 AM

Post#
389174
of 389262
CDIO...4919...🥳Added 40s today...Averaged down to
CDIO
Dcab Dcab 5 minutes ago
The Canadian regulatory system will halt this symbol for ever with one excuse after the other. Unless Finra lifts the halt (which they should) here TWOH stock is worthless. JMHO
TWOH
JusDePomme JusDePomme 5 minutes ago
Nethertheless he is a tycoon in this industry!
AFFU
HyperRaider33 HyperRaider33 5 minutes ago
Maybe you misread my original post. I never said Congress was required to release the GSE's.
FNMA
georgie18 georgie18 5 minutes ago
CDIO...49s starting up again...🥳

georgie18

Member Level
Re: georgie18 post# 388892

Monday, January 27, 2025 11:02:15 AM

Post#
389174
of 389262
CDIO...4919...🥳Added 40s today...Averaged down to
CDIO
MomsSpaghetti MomsSpaghetti 5 minutes ago
MM-120, MindMed’s lead drug candidate, represents a potentially transformative treatment for patients with generalized anxiety disorder (GAD) and other mental health conditions. The promising progress in its development, particularly its Phase 3 trials, suggests a bright future for the drug, MindMed
MNMD
Decon6 Decon6 5 minutes ago
Need a group chat outside of here
EMGE